Most of the preidentified tumor antigen–specific T-cell clones were modestly enriched in the PD1+ 4-1BB+ population compared with starting TIL (Fig. 3C–E and 5B), and some of them were reprogrammed into TIL-iPSCs. The gene discussed is PDCD1; the disease is neoplasm.